Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1986 Apr;39(4):353–365. doi: 10.1136/jcp.39.4.353

Campylobacter pyloridis, gastritis, and peptic ulceration.

C S Goodwin, J A Armstrong, B J Marshall
PMCID: PMC499829  PMID: 3517070

Abstract

Campylobacter pyloridis is a spiral bacterium which was seen by histopathologists several years before it was cultured in 1982 in Perth, Western Australia. It has unique cellular fatty acids, predominantly tetradecanoic acid and cis-11, 12 methylene octadecanoic acid. It also has a unique ultrastructure which is different from that of other campylobacters. C pyloridis possesses a powerful urease enzyme and produces large amounts of extracellular catalase. Both these features may be important virulence factors, allowing it to occupy a protected niche in the stomach below the mucus layer but above the gastric mucosa. Specific lesions are found in the gastric mucosa, and ultrastructural studies show the presence of adherence pedestals identical with those found with enteropathogenic Escherichia coli of the intestine. Histological examination of gastric biopsy tissue has shown that C pyloridis is strongly associated with active chronic gastritis, when polymorphonuclear leucocytes are present, and is not found on normal mucosa except when a biopsy specimen from elsewhere in the stomach shows active chronic gastritis. When patients with symptoms caused by gastritis are identified dual antibacterial treatment, combining the action of bismuth in the stomach with a systemic antibiotic, can eradicate C pyloridis, with remission of symptoms and restoration of normal epithelial morphology. Most peptic ulcers relapse after modern acid reducing treatment, and antibacterial treatment may be beneficial in preventing relapse.

Full text

PDF
353

Images in this article

358Image
on p.358
358Image
on p.358
359Image
on p.359
359Image
on p.359
360Image
on p.360

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen A., Garner A. Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut. 1980 Mar;21(3):249–262. doi: 10.1136/gut.21.3.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bardhan K. D., Cole D. S., Hawkins B. W., Franks C. R. Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J (Clin Res Ed) 1982 Feb 27;284(6316):621–623. doi: 10.1136/bmj.284.6316.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beaney R. P., Lammertsma A. A., Jones T., McKenzie C. G., Halnan K. E. Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet. 1984 Jan 21;1(8369):131–134. doi: 10.1016/s0140-6736(84)90063-1. [DOI] [PubMed] [Google Scholar]
  4. Bolton F. J., Holt A. V., Hutchinson D. N. Urease-positive thermophilic campylobacters. Lancet. 1985 May 25;1(8439):1217–1218. doi: 10.1016/s0140-6736(85)92898-3. [DOI] [PubMed] [Google Scholar]
  5. Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet. 1984 Jun 16;1(8390):1348–1349. [PubMed] [Google Scholar]
  6. Cantey J. R., Blake R. K. Diarrhea due to Escherichia coli in the rabbit: a novel mechanism. J Infect Dis. 1977 Mar;135(3):454–462. doi: 10.1093/infdis/135.3.454. [DOI] [PubMed] [Google Scholar]
  7. Cantey J. R., Lushbaugh W. B., Inman L. R. Attachment of bacteria to intestinal epithelial cells in diarrhea caused by Escherichia coli strain RDEC-1 in the rabbit: stages and role of capsule. J Infect Dis. 1981 Feb;143(2):219–230. doi: 10.1093/infdis/143.2.219. [DOI] [PubMed] [Google Scholar]
  8. Chow A. W., Patten V., Bednorz D. Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrob Agents Chemother. 1978 Mar;13(3):416–418. doi: 10.1128/aac.13.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Christiansen J., Aagaard P., Koudahl G. Truncal vagotomy and drainage in the treatment of ulcer-like dyspepsia without ulcer. Acta Chir Scand. 1973;139(2):173–175. [PubMed] [Google Scholar]
  10. Collins M. D., Costas M., Owen R. J. Isoprenoid quinone composition of representatives of the genus Campylobacter. Arch Microbiol. 1984 Feb;137(2):168–170. doi: 10.1007/BF00414461. [DOI] [PubMed] [Google Scholar]
  11. Curtis M. A. Cellular fatty acid profiles of campylobacters. Med Lab Sci. 1983 Oct;40(4):333–348. [PubMed] [Google Scholar]
  12. Davenport H. W. Salicylate damage to the gastric mucosal barrier. N Engl J Med. 1967 Jun 8;276(23):1307–1312. doi: 10.1056/NEJM196706082762308. [DOI] [PubMed] [Google Scholar]
  13. Fung W. P., Papadimitriou J. M., Matz L. R. Endoscopic, histological and ultrastructural correlations in chronic gastritis. Am J Gastroenterol. 1979 Mar;71(3):269–279. [PubMed] [Google Scholar]
  14. Gear M. W., Truelove S. C., Whitehead R. Gastric ulcer and gastritis. Gut. 1971 Aug;12(8):639–645. doi: 10.1136/gut.12.8.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gledhill T., Leicester R. J., Addis B., Lightfoot N., Barnard J., Viney N., Darkin D., Hunt R. H. Epidemic hypochlorhydria. Br Med J (Clin Res Ed) 1985 May 11;290(6479):1383–1386. doi: 10.1136/bmj.290.6479.1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Goodwin C. S., Armstrong J. A. Will antibacterial chemotherapy be efficacious for gastritis and peptic ulcer? J Antimicrob Chemother. 1986 Jan;17(1):1–3. doi: 10.1093/jac/17.1.1. [DOI] [PubMed] [Google Scholar]
  17. Goodwin C. S., Blincow E. D., Warren J. R., Waters T. E., Sanderson C. R., Easton L. Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol. 1985 Oct;38(10):1127–1131. doi: 10.1136/jcp.38.10.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Goodwin C. S., McCulloch R. K., Armstrong J. A., Wee S. H. Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol. 1985 Apr;19(2):257–267. doi: 10.1099/00222615-19-2-257. [DOI] [PubMed] [Google Scholar]
  19. Goodwin S., Blincow E., Armstrong J., McCulloch R., Collins D. Campylobacter pyloridis is unique: GCLO-2 is an ordinary campylobacter. Lancet. 1985 Jul 6;2(8445):38–39. doi: 10.1016/s0140-6736(85)90082-0. [DOI] [PubMed] [Google Scholar]
  20. Hovind-Hougen K., Birch-Andersen A., Henrik-Nielsen R., Orholm M., Pedersen J. O., Teglbjaerg P. S., Thaysen E. H. Intestinal spirochetosis: morphological characterization and cultivation of the spirochete Brachyspira aalborgi gen. nov., sp. nov. J Clin Microbiol. 1982 Dec;16(6):1127–1136. doi: 10.1128/jcm.16.6.1127-1136.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hughes K., Robertson D. A., James W. B. Duodeno-gastric reflux in normal and dyspeptic subjects. Clin Radiol. 1982 Jul;33(4):461–466. doi: 10.1016/s0009-9260(82)80320-6. [DOI] [PubMed] [Google Scholar]
  22. Jones D. M., Lessells A. M., Eldridge J. Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies. J Clin Pathol. 1984 Sep;37(9):1002–1006. doi: 10.1136/jcp.37.9.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kaldor J., Tee W., McCarthy P., Watson J., Dwyer B. Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet. 1985 Apr 20;1(8434):921–921. doi: 10.1016/s0140-6736(85)91687-3. [DOI] [PubMed] [Google Scholar]
  24. Lambert J. R., Dunn K. L., Eaves E. R., Korman M. G., Hansky J., Pinkard K. J. Pyloric CLO in the human stomach. Med J Aust. 1985 Aug 19;143(4):174–174. doi: 10.5694/j.1326-5377.1985.tb122895.x. [DOI] [PubMed] [Google Scholar]
  25. Lechevalier M. P. Lipids in bacterial taxonomy - a taxonomist's view. CRC Crit Rev Microbiol. 1977;5(2):109–210. doi: 10.3109/10408417709102311. [DOI] [PubMed] [Google Scholar]
  26. Mackay I. R., Hislop I. G. Chronic gastritis and gastric ulcer. Gut. 1966 Jun;7(3):228–233. doi: 10.1136/gut.7.3.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Marshall B. J., Armstrong J. A., McGechie D. B., Glancy R. J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust. 1985 Apr 15;142(8):436–439. doi: 10.5694/j.1326-5377.1985.tb113443.x. [DOI] [PubMed] [Google Scholar]
  28. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  29. McLean A. J., Harrison P. M., Ioannides-Demos L. L., Byrne A. J., McCarthy P., Dudley F. J. Microbes, peptic ulcer, and relapse rates with different drugs. Lancet. 1984 Sep 1;2(8401):525–526. doi: 10.1016/s0140-6736(84)92607-2. [DOI] [PubMed] [Google Scholar]
  30. McLean A. J., Harrison P. M., Ioannides-Demos L., Byrne A. J., McCarthy P., Dudley F. J. The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome. Aust N Z J Med. 1985 Jun;15(3):367–374. doi: 10.1111/j.1445-5994.1985.tb04065.x. [DOI] [PubMed] [Google Scholar]
  31. McNulty C. A., Watson D. M. Spiral bacteria of the gastric antrum. Lancet. 1984 May 12;1(8385):1068–1069. doi: 10.1016/s0140-6736(84)91469-7. [DOI] [PubMed] [Google Scholar]
  32. Pead P. J. Electron microscopy of Campylobacter jejuni. J Med Microbiol. 1979 Aug;12(3):383–385. doi: 10.1099/00222615-12-3-383. [DOI] [PubMed] [Google Scholar]
  33. Phillips M. W., Lee A. Isolation and characterization of a spiral bacterium from the crypts of rodent gastrointestinal tracts. Appl Environ Microbiol. 1983 Feb;45(2):675–683. doi: 10.1128/aem.45.2.675-683.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Prichard P. J., Rubinstein D., Jones D. B., Dudley F. J., Smallwood R. A., Louis W. J., Yeomans N. D. Double blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcers. Br Med J (Clin Res Ed) 1985 Feb 23;290(6468):601–603. doi: 10.1136/bmj.290.6468.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ramsey E. J., Carey K. V., Peterson W. L., Jackson J. J., Murphy F. K., Read N. W., Taylor K. B., Trier J. S., Fordtran J. S. Epidemic gastritis with hypochlorhydria. Gastroenterology. 1979 Jun;76(6):1449–1457. [PubMed] [Google Scholar]
  36. Rathbone B. J., Wyatt J. I., Worsley B. W., Trejdosiewicz L. K., Heatley R. V., Losowsky M. S. Immune response to Campylobacter pyloridis. Lancet. 1985 May 25;1(8439):1217–1217. doi: 10.1016/s0140-6736(85)92897-1. [DOI] [PubMed] [Google Scholar]
  37. Rollason T. P., Stone J., Rhodes J. M. Spiral organisms in endoscopic biopsies of the human stomach. J Clin Pathol. 1984 Jan;37(1):23–26. doi: 10.1136/jcp.37.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rothbaum R., McAdams A. J., Giannella R., Partin J. C. A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology. 1982 Aug;83(2):441–454. [PubMed] [Google Scholar]
  39. Rune S. J. Acid-base parameters of duodenal contents in man. Gastroenterology. 1972 Apr;62(4):533–539. [PubMed] [Google Scholar]
  40. Schrager J., Spink R., Mitra S. The antrum in patients with duodenal and gastric ulcers. Gut. 1967 Oct;8(5):497–508. doi: 10.1136/gut.8.5.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shanker S., Sorrell T. C. Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology. 1983 Jan;15(1):61–63. doi: 10.3109/00313028309061403. [DOI] [PubMed] [Google Scholar]
  42. Shirokova K. I., Filimonov R. M., Poliakova L. V. Primenenie metronidazola v lechenii bol'nykh iazvennoi bolezn'iu. Klin Med (Mosk) 1981 Feb;59(2):48–50. [PubMed] [Google Scholar]
  43. Snooks S. J., Henry M. M., Swash M. Anorectal incontinence and rectal prolapse: differential assessment of the innervation to puborectalis and external anal sphincter muscles. Gut. 1985 May;26(5):470–476. doi: 10.1136/gut.26.5.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Steele T. W., Lanser J. A., Sangster N. Nitrate-negative campylobacter-like organisms. Lancet. 1985 Feb 16;1(8425):394–394. doi: 10.1016/s0140-6736(85)91410-2. [DOI] [PubMed] [Google Scholar]
  45. Steer H. W., Colin-Jones D. G. Mucosal changes in gastric ulceration and their response to carbenoxolone sodium. Gut. 1975 Aug;16(8):590–597. doi: 10.1136/gut.16.8.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Steer H. W. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut. 1984 Nov;25(11):1203–1210. doi: 10.1136/gut.25.11.1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Steer H. W. Ultrastructure of cell migration throught the gastric epithelium and its relationship to bacteria. J Clin Pathol. 1975 Aug;28(8):639–646. doi: 10.1136/jcp.28.8.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Svedhem A., Gunnarsson H., Kaijser B. Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni. J Infect Dis. 1983 Jul;148(1):82–92. doi: 10.1093/infdis/148.1.82. [DOI] [PubMed] [Google Scholar]
  49. Takeuchi A., Inman L. R., O'Hanley P. D., Cantey J. R., Lushbaugh W. B. Scanning and transmission electron microscopic study of Escherichia coli O15 (RDEC-1) enteric infection in rabbits. Infect Immun. 1978 Feb;19(2):686–694. doi: 10.1128/iai.19.2.686-694.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Talley N. J. The pathogenesis of non-ulcer dyspepsia. Med J Aust. 1985 Aug 19;143(4):173–174. [PubMed] [Google Scholar]
  51. Tatsuta M., Okuda S., Tamura H., Taniguchi H. Endoscopic diagnosis of early gastric cancer by the endoscopic Congo red-methylene blue test. Cancer. 1982 Dec 15;50(12):2956–2960. doi: 10.1002/1097-0142(19821215)50:12<2956::aid-cncr2820501242>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  52. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  53. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  54. Whitehead R., Truelove S. C., Gear M. W. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol. 1972 Jan;25(1):1–11. doi: 10.1136/jcp.25.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zhao H. Y., Li G. Z., Guo J. D., Yan Z., Sun S. W., Li L. S., Duan Y. M., Yue F. Z. Furazolidone in peptic ulcer. Lancet. 1985 Aug 3;2(8449):276–277. [PubMed] [Google Scholar]
  56. Zheng Z. T., Wang Z. Y., Chu Y. X., Li Y. N., Li Q. F., Lin S. R., Xu Z. M. Double-blind short-term trial of furazolidone in peptic ulcer. Lancet. 1985 May 4;1(8436):1048–1049. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES